Tafamidis

Category: Genetic Disorders



Tafamidis Overview

Tafamidis (trade name Vyndaqel)[2] is a medication used to delay loss of peripheral nerve function in adults with familial amyloid polyneuropathy (FAP). It works by stabilizing the protein, transthyretin, which is normally made up of four strands. In people with FAP these strands separate and form clumps that harm nerves. The medication was approved for medical use in Europe in 2011 and in Japan in 2013.[3][4] It was initially rejected in the ...

Read more Tafamidis Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tafamidis

Recent Tafamidis Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tafamidis
  • Capsule: 20mg, 61mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Tafamidis or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 February 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA